Navigation Links
IUPUI faculty member to receive national innovative vision research award
Date:4/19/2011

INDIANAPOLIS Jason S. Meyer, Ph.D., assistant professor of biology in the School of Science at Indiana University-Purdue University Indianapolis, will be honored by the largest eye and vision research organization in the world for work which one day may lead to reversal of blindness caused by macular degeneration, retinitis pigmentosa and other diseases of the retina.

The Association for Research in Vision and Ophthalmology (ARVO) will present Meyer with a 2011 ARVO-AFER/Merck Innovative Ophthalmology Research Award at the organization's annual meeting in Fort Lauderdale, Fla., on May 1.

Meyer is being recognized for a study he published in the Proceedings of the National Academy of Sciences (PNAS) in 2009. The paper, "Modeling Early Retinal Development with Human Embryonic and Induced Pluripotent Stem Cells" provides an important step toward the potential repair of damaged retinas by cells grown from a patient's own skin.

"In the PNAS study, we were able to produce significant numbers of photoreceptor cells and other retinal cell types which are lost in many blinding disorders. Our work could serve as a foundation for unlocking the mechanisms that produce human retinal cells," said Meyer, who co-directed the study when he previously worked at the University of Wisconsin.

A developmental biologist, he continues this promising line of research in his laboratory at the School of Science at IUPUI utilizing the recently (2007) developed and not yet common technology of induced pluripotent stem (iPS) cells.

"Since iPS cells can be derived from patients with a specific known disease, these cells could help us study neurological disorders like those of the retina, the auditory system and other parts of the body, in novel ways at both the cellular and subcellular levels, bringing us closer to therapeutic approaches," said Meyer.

Now that he and colleagues have reprogrammed skin cells into stem cells that can become any cell type of the body, and then triggered the development of retinal cell types, Meyer believes that clinical trials and eventually treatment of retinal diseases with iPS cells is only a matter of time. Since they can be derived from the specific patient who needs them, use of iPS cells avoids the problem of transplant rejection.

Human iPS cells can be obtained from a single paper punch-hole size slice of easily accessible skin requiring only one or two stitches following the removal procedure.

Meyer will receive a $10,000 grant as the second prize recipient in the stem cell applications to eye disease category. The awards, open to researchers aged 45 years or younger who hold a doctoral degree, are presented biennially. This is only the second year in which an American has received the award.

Meyer joined the School of Science at IUPUI faculty in 2010, the second year consecutive year the School of Science recruited a record number of new faculty.


'/>"/>

Contact: Cindy Fox Aisen
caisen@iupui.edu
317-274-7722
Indiana University-Purdue University Indianapolis School of Science
Source:Eurekalert  

Related medicine news :

1. Molecules made by IUPUI students may have potential to cure diseases
2. International recognition for IUPUI work to improve breast cancer detection
3. Faculty of 1000 launch Ophthalmology Faculty
4. UofL Area Health Education Centers faculty, students make $6.8 million economic impact
5. Report offers solutions to address decline in US dental faculty
6. Dartmouth Medical School faculty named fellows of the American Association for the Advancement of Science
7. Mapping faculty social networks helps female faculty move ahead at NJIT
8. $1 million awarded to Bloomberg Faculty of Nursing-led research team
9. Salaries, demand and career opportunities contribute to global nursing faculty migration
10. Hopkins faculty lead development of report to FDA on ethical, scientific issues related to post-market clinical trials
11. World Renowned Total Artificial Heart Pioneer Dr. Jack Copeland Joins Faculty at UC San Diego
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
IUPUI faculty member to receive national innovative vision research award
(Date:4/29/2016)... ... 29, 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 ... skin cancer deaths. More than 10,000 people are expected to die of melanoma this year. ... is the one of the most commonly diagnosed cancers in young women. A recent breakthrough ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... Dairy Products, Inc. in an upcoming episode, airing third quarter 2016 via Discovery ... churning cream into butter, Grassland Dairy Products, located in Greenwood, Wisconsin applies product ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at HRC Fertility/Orange County ... Dr. Daniel A. Potter -- are proud of the recent release of their 2014 ... April, SART published the latest verified data for 375 U.S. member clinics. ...
(Date:4/29/2016)... ... 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend and sponsor ... the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event is the ... protein ingredients. , At the seminar, IDF™ will offer samples of its Savory ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... , Net Sales of $1.90 billion represent an increase ... period, and an increase of 1.2% on an adjusted pro ... first quarter were $0.52 reported, a decrease of 47.5% from ... 29.9% over the prior year period , The Company ... Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) ...
(Date:4/28/2016)... April 28, 2016  ValGenesis, Inc., the ... Solutions (VLMS) today announced that a prominent ... sufferers of chronic kidney failure has selected ... their corporate validation process. The global medical ... solution to manage their validation processes electronically. ...
(Date:4/27/2016)... , Schweiz, April 27, 2016 /PRNewswire/ ... des Sachs CEO Forums in Zürich gab ... ihres führenden Wirkstoffkandidaten STR001 zur Erhaltung des ... eingesetzt wurde, bekannt. Für die umfassende Phase-II-Doppelblindstudie ... und Frankreich angeworben. STR001 wird während der ...
Breaking Medicine Technology: